Literature DB >> 15874821

Self-reported pain intensity and associated distress in children aged 4-18 years on admission, discharge, and one-week follow up to emergency department.

C Celeste Johnston1, Marie-Christine Bournaki, Anita J Gagnon, Carolyn J Pepler, Patricia Bourgault.   

Abstract

OBJECTIVES: Pain is the most common complaint among children presenting to the Emergency Department (ED), yet it is poorly managed. Although the poor management of pain has been documented, no studies have simultaneously determined the distress caused by the presenting pain nor have children been followed after the ED visit to determine whether the pain and distress have resolved. The purpose of this study was to describe pain intensity, distress from pain, and treatment of pain in children presenting to the ED and to follow them 1 week later to describe resolution of their pain.
METHODS: A survey design with follow up of patients identified with pain in 2 urban university-affiliated pediatric EDs with children between ages 4 and 18 (N = 533). Measures used included the Coloured Analogue Scale (CAS) for both pain and distress related to pain, mobility problems related to pain, and interference with activities of daily living due to pain. Chart reviews were conducted for documentation of pain assessment and analgesic administration and prescription at discharge.
RESULTS: Half of the children presenting were experiencing pain due to musculoskeletal injury and two-thirds of the pain problems had an onset within 48 hours of presentation to the ED. Mean pain intensity on admission was 5.2 (SD 2.3) and at discharge was 4.1 (SD 2.7), however, 22% had worsening of pain and for 26%, the pain remained the same. On admission, 12.8% reported pain intensity 8/10 or more but 23% reported distress levels 8/10 or more. Only 39% received analgesics during the visit and 11% were given a prescription for analgesics at discharge. Children (n = 104) were reached 1 week following discharge from ED and only 5% were reporting pain of 4/10 or more but, of those reporting any pain at all, 34% reported distress from their pain of 4/10 or more.
CONCLUSIONS: A greater proportion of children report high intensity of distress from pain than of pain intensity itself when in the ED. Only a small proportion of children received analgesics during the visit to the ED and only slightly more on discharge. Although pain seems to resolve by 1 week, distress is less likely to have resolved. More attention needs to be paid both to pain children are experiencing in the ED and equally to the accompanying distress.

Entities:  

Mesh:

Year:  2005        PMID: 15874821     DOI: 10.1097/01.pec.0000159067.09573.f1

Source DB:  PubMed          Journal:  Pediatr Emerg Care        ISSN: 0749-5161            Impact factor:   1.454


  5 in total

1.  Pediatric nurses' beliefs and pain management practices: an intervention pilot.

Authors:  Catherine Van Hulle Vincent; Diana J Wilkie; Edward Wang
Journal:  West J Nurs Res       Date:  2010-12-20       Impact factor: 1.967

2.  Opioid Prescription Patterns at Emergency Department Discharge for Children with Fractures.

Authors:  Amy L Drendel; David C Brousseau; T Charles Casper; Lalit Bajaj; Evaline A Alessandrini; Robert W Grundmeier; James M Chamberlain; Monika K Goyal; Cody S Olsen; Elizabeth R Alpern
Journal:  Pain Med       Date:  2020-09-01       Impact factor: 3.750

3.  Pediatric procedural pain: how far have we come? An ethnographic account.

Authors:  Jo Ann F Cummings
Journal:  Pain Manag Nurs       Date:  2015-06       Impact factor: 1.929

4.  Pediatric nurses' cognitive representations of children's pain.

Authors:  Catherine Van Hulle Vincent; Diana J Wilkie; Laura Szalacha
Journal:  J Pain       Date:  2010-04-24       Impact factor: 5.820

5.  An assessment of the psychometric properties of the Stoplight Pain Scale in a Canadian paediatric emergency department.

Authors:  Samina Ali; Ellen Morrison; Seyara Shwetz; Maryna Yaskina; Manasi Rajagopal; Andrea Estey; Amy L Drendel
Journal:  Paediatr Child Health       Date:  2021-05-26       Impact factor: 2.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.